IN2013MU03424A - - Google Patents

Info

Publication number
IN2013MU03424A
IN2013MU03424A IN3424MU2013A IN2013MU03424A IN 2013MU03424 A IN2013MU03424 A IN 2013MU03424A IN 3424MU2013 A IN3424MU2013 A IN 3424MU2013A IN 2013MU03424 A IN2013MU03424 A IN 2013MU03424A
Authority
IN
India
Prior art keywords
core
relates
composition
oxcarbazepine
salts
Prior art date
Application number
Other languages
English (en)
Inventor
Girish Kumar Jain
Manohar Lalge
Vinayak Kadam
Original Assignee
Wockhardt Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wockhardt Ltd filed Critical Wockhardt Ltd
Priority to IN3424MU2013 priority Critical patent/IN2013MU03424A/en
Priority to PCT/IB2014/065638 priority patent/WO2015063670A1/en
Publication of IN2013MU03424A publication Critical patent/IN2013MU03424A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IN3424MU2013 2013-10-30 2014-10-27 IN2013MU03424A (hu)

Priority Applications (2)

Application Number Priority Date Filing Date Title
IN3424MU2013 IN2013MU03424A (hu) 2013-10-30 2014-10-27
PCT/IB2014/065638 WO2015063670A1 (en) 2013-10-30 2014-10-27 Solid oral modified-release composition comprising oxcarbazepine or a pharmaceutically acceptable salt thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN3424MU2013 IN2013MU03424A (hu) 2013-10-30 2014-10-27

Publications (1)

Publication Number Publication Date
IN2013MU03424A true IN2013MU03424A (hu) 2015-07-31

Family

ID=54397476

Family Applications (1)

Application Number Title Priority Date Filing Date
IN3424MU2013 IN2013MU03424A (hu) 2013-10-30 2014-10-27

Country Status (1)

Country Link
IN (1) IN2013MU03424A (hu)

Similar Documents

Publication Publication Date Title
MX2021007268A (es) Formas solidas de acido {[5-(3-clorofenil)-3-hidroxipiridin-2-carb onil]amino}acetico, composiciones, y usos de las mismas.
UY32427A (es) Composicion farmaceutica, forma farmaceutica, procedimiento para su preparacion, metodos de tratamiento y usos de la misma
TN2011000370A1 (en) Alkylamine-substituted dicyanopyridine and amino acid ester prodrugs thereof
TN2014000138A1 (en) Substituted benzylindazoles for use as bub1 kinase inhibitors in the treatment of hyperproliferative diseases.
BR112012027509A8 (pt) Composto pirazolil-quinoxalina inibidor de quinase, combinação, produto, processo para a preparação de um composto, composição farmacêutica, uso de um composto, e método
CL2011002267A1 (es) Compuesto derivado de pirazolopiridina sustituida, inhibidor de la quinasa lrrk2; procedimiento de preparacion de dicho compuesto; composicion farmaceutica; combinacion farmaceutica; uso del compuesto para prevenir o tratar un trastorno seleccionado de cancer y enfermedades neurodegenerativas.
MX337605B (es) Derivados de fumarato de acido graso y sus usos.
NZ705578A (en) Coated pharmaceutical composition containing regorafenib
HK1243424A1 (zh) 4'-硫代核苷的新型化合物及其製備方法、藥物組合物和應用
GEP20156231B (en) Agomelatine hydrochloride hydrate and preparation there of
MX370113B (es) Moduladores alostericos positivos del receptor muscarinico m2.
MX2017015137A (es) Composicion farmaceutica oral de dosis diaria de isotretinoin.
ES2421956A1 (es) Nueva forma cristalina de sulfato de sitagliptina
MX342976B (es) Uso de melatonina para el tratamiento y/o prevencion de la mucositis.
EA033769B9 (ru) Отселектированный амид -гидроксимасляной кислоты и его применения при лечении злоупотребления алкоголем
WO2015075062A3 (en) Method of treating hair
MX2015007945A (es) Usos y métodos para el tratamiento de enfermedades o afecciones hepáticas.
BR112016007031A8 (pt) composição farmacêutica oral sólida, processo para preparar a composição farmacêutica oral sólida, e uso de uma composição farcêutica oral sólida
IN2013MU03424A (hu)
GEP20156232B (en) Agomelatine hydrochloride hydrate and preparation thereof
UA110933C2 (uk) Композиція для лікування есенціальної тромбоцитемії
IN2013MU03423A (hu)
IN2013MU03426A (hu)
IN2014DN10683A (hu)
PH12019501689A1 (en) Composition comprising immediate release and extended release capecitabine